These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7908163)

  • 21. Optimal medical management of patients with chronic ischemic heart disease.
    O'Rourke RA
    Curr Probl Cardiol; 2001 Mar; 26(3):189-238. PubMed ID: 11305088
    [No Abstract]   [Full Text] [Related]  

  • 22. Amlodipine reduces myocardial ischaemia during exercise without compromising left ventricular function in patients with silent ischaemia: a randomised, double-blind, placebo-controlled study.
    Bech J; Madsen JK; Kelbaek H
    Eur J Heart Fail; 1999 Dec; 1(4):395-400. PubMed ID: 10937953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of myocardial ischemia and left ventricular function in patients with angina pectoris without myocardial infarction and total occlusion of the left anterior descending coronary artery and collaterals from other coronary arteries.
    Juillière Y; Marie PY; Danchin N; Karcher G; Bertrand A; Cherrier F
    Am J Cardiol; 1991 Jul; 68(1):7-12. PubMed ID: 2058562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by biosense left ventricular electromechanical mapping.
    Kornowski R; Baim DS; Moses JW; Hong MK; Laham RJ; Fuchs S; Hendel RC; Wallace D; Cohen DJ; Bonow RO; Kuntz RE; Leon MB
    Circulation; 2000 Sep; 102(10):1120-5. PubMed ID: 10973840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy.
    Slavich M; Maranta F; Fumero A; Godino C; Giannini F; Oppizzi M; Colombo A; Fragasso G; Margonato A
    Am J Cardiol; 2016 May; 117(10):1558-1561. PubMed ID: 27055755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ischemia: outcome with medical therapy versus revascularization.
    Miller TD; Christian TF; Taliercio CP; Zinsmeister AR; Orszulak TA; Schaff HV; Gibbons RJ
    Mayo Clin Proc; 1994 Jul; 69(7):626-31. PubMed ID: 8015324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategy for identifying an efficient dosage of beta-blocker for elderly patients with myocardial ischemia and preserved left ventricular function.
    Serro-Azul JB; Wajngarten M; Nussbacher A; Giorgi MC; Meneghetti JC; de Oliveira MA; Abe R; Dal Bó C; Pierri H; Gebara O
    Arq Bras Cardiol; 2004 Jun; 82(6):551-8. PubMed ID: 15257372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy.
    Bonow RO; Kent KM; Rosing DR; Lan KK; Lakatos E; Borer JS; Bacharach SL; Green MV; Epstein SE
    N Engl J Med; 1984 Nov; 311(21):1339-45. PubMed ID: 6333637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of resting and submaximal exercise radionuclide ventriculography after acute myocardial infarction in high-risk patients with single and multivessel disease.
    Nicod P; Corbett JR; Firth BG; Lewis SE; Rude RE; Huxley R; Willerson JT
    Am J Cardiol; 1983 Jul; 52(1):30-6. PubMed ID: 6858923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
    Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
    Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect on treadmill exercise capacity, myocardial ischemia, and left ventricular function as a result of repeated whole-body periodic acceleration with heparin pretreatment in patients with angina pectoris and mild left ventricular dysfunction.
    Miyamoto S; Fujita M; Inoko M; Oba M; Hosokawa R; Haruna T; Izumi T; Saji Y; Nakane E; Abe T; Ueyama K; Nohara R
    Am J Cardiol; 2011 Jan; 107(2):168-74. PubMed ID: 21129712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implications of symptomatic versus asymptomatic (silent) myocardial ischemia induced by exercise in mildly symptomatic and in asymptomatic patients with angiographically documented coronary artery disease.
    Bonow RO; Bacharach SL; Green MV; LaFreniere RL; Epstein SE
    Am J Cardiol; 1987 Oct; 60(10):778-83. PubMed ID: 3661392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term treatment with calcium antagonists on left ventricular diastolic function in stable angina and heart failure.
    Lahiri A; Rodrigues EA; Carboni GP; Raftery EB
    Circulation; 1990 Feb; 81(2 Suppl):III130-8. PubMed ID: 2404636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of coronary artery bypass grafting on left ventricular systolic function at rest: evidence for preoperative subclinical myocardial ischemia.
    Dilsizian V; Bonow RO; Cannon RO; Tracy CM; Vitale DF; McIntosh CL; Clark RE; Bacharach SL; Green MV
    Am J Cardiol; 1988 Jun; 61(15):1248-54. PubMed ID: 3259832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-ischemic intervention as prognosis improvement in patients with coronary artery disease, with special focus on verapamil.
    Jespersen CM
    Am J Cardiol; 1996 Jun; 77(16):32D-36D. PubMed ID: 8677896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
    Erne P; Schoenenberger AW; Burckhardt D; Zuber M; Kiowski W; Buser PT; Dubach P; Resink TJ; Pfisterer M
    JAMA; 2007 May; 297(18):1985-91. PubMed ID: 17488963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of radionuclide measurements of left ventricular function for prognosis in patients with coronary artery disease.
    Jones RH
    Semin Nucl Med; 1987 Apr; 17(2):95-103. PubMed ID: 3589679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angina pectoris and silent ischemia in the elderly: a management update.
    Lazar EJ; Lazar JM; Frishman W
    Geriatrics; 1992 Jul; 47(7):24-8, 35-6. PubMed ID: 1352266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.